Literature DB >> 4053973

Hypothalamus-pituitary-adrenal axis of heroin addicts.

F Facchinetti, A Volpe, G Farci, F Petraglia, C A Porro, G Barbieri, A Cioni, A Balestrieri, A R Genazzani.   

Abstract

The hypothalamus-pituitary-adrenal axis of heroin addicts was investigated by evaluating plasma cortisol levels throughout the day in 37 heroin abusers (HA), 17 of whom showed detectable morphine levels, indicating heroin administration in the previous hours and in 12 controls. All HA showed lower cortisol levels in basal condition (100.7 +/- 61.7 ng/ml, M +/- S.D.) compared to the control group (159.7 +/- 40.6, P less than 0.05). Moreover all HA (65.1 +/- 28.9%), and in particular those taking heroin during the study (39.1 +/- 41.4%), show a reduced cortisol decrease in the evening, which was significantly lower than in controls (85.3 +/- 10.1%; P less than 0.01). As far as the acute effects of opiates are concerned morphine (0.1 mg/kg) significantly reduced plasma cortisol levels within 60 min in a group of 8 healthy subjects. The same pattern was displayed by only 3/8 HA whose morphine levels were higher than 1 ng/ml, i.e. in those reaching the highest plasma morphine concentrations. These data indicate that chronic opiate abuse leads to a hypoadrenalism which could be the result of morphine-induced changes at the hypothalamic level.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053973     DOI: 10.1016/0376-8716(85)90014-6

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  9 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance.

Authors:  Kellie M Jaremko; Robert C Sterling; Elisabeth J Van Bockstaele
Journal:  J Subst Abuse Treat       Date:  2014-08-29

Review 3.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 4.  Behavioral predictors of individual differences in opioid addiction vulnerability as measured using i.v. self-administration in rats.

Authors:  Yayi Swain; Jonathan C Gewirtz; Andrew C Harris
Journal:  Drug Alcohol Depend       Date:  2021-01-29       Impact factor: 4.492

5.  The relationship between alcohol consumption, perceived stress, and CRHR1 genotype on the hypothalamic-pituitary-adrenal axis in rural African Americans.

Authors:  Ezemenari M Obasi; Elizabeth A Shirtcliff; Gene H Brody; James MacKillop; Delishia M Pittman; Lucia Cavanagh; Robert A Philibert
Journal:  Front Psychol       Date:  2015-06-18

6.  Elevated Hair Cortisol Levels among Heroin Addicts on Current Methadone Maintenance Compared to Controls.

Authors:  Jin Yang; Jifeng Li; Guanyi Xu; Jing Zhang; Zheng Chen; Zuhong Lu; Huihua Deng
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

7.  Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward.

Authors:  Rui Zhang; Peter Manza; Dardo Tomasi; Sung Won Kim; Ehsan Shokri-Kojori; Sukru B Demiral; Danielle S Kroll; Dana E Feldman; Katherine L McPherson; Catherine L Biesecker; Gene-Jack Wang; Nora D Volkow
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

8.  A case of hypogonadotropic hypogonadism caused by opioid treatment for nonmalignant chronic pain.

Authors:  Yukiko Tabuchi; Tetsuyuki Yasuda; Hideaki Kaneto; Tetsuhiro Kitamura; Junji Kozawa; Michio Otsuki; Akihisa Imagawa; Aya Nakae; Youichi Matsuda; Hironobu Uematsu; Takashi Mashimo; Masahiko Shibata; Iichiro Shimomura
Journal:  Case Rep Med       Date:  2012-12-25

9.  Loperamide-induced hypopituitarism.

Authors:  Catherine Napier; Earn H Gan; Simon H S Pearce
Journal:  BMJ Case Rep       Date:  2016-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.